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KINETICS	
PON1	in	human	plasma	Recombinant	PON1-G3C9	
Fig.	5	–	Enzyme	ac0vi0es	as	a	func0on	of	paraoxon	concentra0on	in	2	mM	CaCl2,	200	mM	KCl,	100	mM	Tris-HCl	pH	7.6	suppor0ng	electrolyte,	37	ºC.	Solid	lines	
represent	the	Michaelis-Menten	simula0ons	of	the	enzyme	kine0cs.	
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CONCLUSIONS	AND	FUTURE	WORK	
q  A	novel	electrochemical	methodology	was	developed	for	the	measurement	of	human	PON1	ac0vity	in	plasma.	
q  The	 lactonase	 ac0vity	 from	 the	 recombinant	 PON1-G3C9	 was	 monitored	 by	 cyclic	 voltammetry,	 and	 will	 be	 further	
op0mized.	
q  The	paraoxonase	ac0vity	of	recombinant	PON1-G3C9	is	higher	than	its	lactonase	ac0vity.	
q  In	 the	 near	 future,	 other	 recombinant	 PON1	with	 higher	 ac0vity	 towards	 lactones	will	 be	 tested	 for	 the	 detec0on	 of	
homocysteine-thiolactone.	
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Fig.	 3	 –	 Enzima0c	 conversion	 of	 paraoxon	 into	 p-nitrophenol,	 monitored	 by	
square	wave	 voltammetry	 (freq.	 25	Hz).	 Suppor0ng	electrolyte:	 2	mM	CaCl2,	
200	mM	KCl,	100	mM	Tris-HCl	buﬀer	(pH	7.6,	37	ºC).	Inset:	controls	performed	
in	the	absence	of	CaCl2	 (black)	and	enzyme	(red);	no	conversion	of	paraoxon	
into	p-nitrophenol	is	observed	aqer	30	minutes.	
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Fig.	4	–	Enzyma0c	conversion	of	1	mM	Hcy-TL	into	Hcy	by	recombinant	PON1-
G3C9,	 monitored	 by	 cyclic	 voltammetry	 (scan	 rate	 50	 mV.s-1).	 Suppor0ng	
electrolyte:	2	mM	CaCl2,	200	mM	KCl,	100	mM	Tris-HCl	buﬀer	(pH	7.6,	37	ºC).	
Inset:	 electrode’s	 response	 aqer	 30	 min	 in	 the	 presence	 (red)	 and	 absence	
(black)	of	enzyme.	
LACTONASE	ACTIVITY	
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Elevated	 plasma	 levels	 of	 homocysteine	 (Hcy),	 and	 its	 conversion	 into	
the	 reac0ve	 metabolite	 Hcy-thiolactone	 (Hcy-TL)	 are	 linked	 to	 the	
progression	of	Cardiovascular	Diseases	(CVD).	Providing	a	novel	point-of-
care	 test	 for	 Hcy-TL	 can	 represent	 a	 major	 breakthrough	 in	 CVD	 risk	
assessment	 [1].	 Since	 the	 detoxiﬁca0on	 of	 Hcy-TL	 by	 human	 HDL-
associated	enzyme	paraxonase	1	 (PON1)	 [2]	can	generate	electroac0ve	
products,	 our	 novel	 strategy	 relies	 on	 developing	 a	 sensing	 device	 for	
Hcy-TL	that	couples	PON1	to	an	electrochemical	transducer.		
Herein,	 we	 analyzed	 the	 cataly0c	 ac0vi0es	 of	 human	 PON1	
(recombinant	G3C9	vs	plasma)	–	paraoxonase	(Fig.	1)	and	lactonase	(Fig.	
2)	by	electrochemical	techniques	aiming	at	developing	a	ﬁrst	genera0on	
electrochemical	biosensor	based	on	this	biorecogni0on	element.	
INTRODUCTION	
Fig.	1	–	Cataly0c	conversion	of	paraoxon	
into	p-nitrophenol	by	PON1	[2].	
Hcy-TL	 Hcy	
Fig.	2	–	Cataly0c	conversion	of	Hcy-TL	into	
Hcy	by	PON1.	
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